{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:45:14Z","timestamp":1792118714614,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100027043","name":"Milken Institute","doi-asserted-by":"publisher","award":["2021-0825"],"award-info":[{"award-number":["2021-0825"]}],"id":[{"id":"10.13039\/100027043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["CHRPJ-508393-2017"],"award-info":[{"award-number":["CHRPJ-508393-2017"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CPG-151963"],"award-info":[{"award-number":["CPG-151963"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134385","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:59:00Z","timestamp":1722869940000},"page":"134385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P4","title":["In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders"],"prefix":"10.1016","volume":"277","author":[{"given":"Andrew","family":"Lofts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Campea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Winterhelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Rigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahieli Preciado","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Hoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.134385_bb0005","unstructured":"\u201cSchizophrenia.\u201d https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schizophrenia (accessed Feb. 17, 2023)."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0010","series-title":"Olanzapine","author":"Thomas","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103307","article-title":"The gut microbiome influences the bioavailability of olanzapine in rats","volume":"66","author":"Cussotto","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0020","doi-asserted-by":"crossref","unstructured":"Y. K. Katare et al., \u201cIntranasal delivery of antipsychotic drugs,\u201d Schizophr. Res., vol. 184, pp. 2\u201313, Jun. 2017, doi:https:\/\/doi.org\/10.1016\/J.SCHRES.2016.11.027.","DOI":"10.1016\/j.schres.2016.11.027"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134385_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory - design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0030","first-page":"1","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"2022","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13086","article-title":"The SNAP 101 double-blind, placebo\/active-controlled, safety, pharmacokinetic, and pharmacodynamic study of INP105 (nasal olanzapine) in healthy adults","volume":"81","author":"Shrewsbury","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.865590","article-title":"Advances and challenges in intranasal delivery of antipsychotic agents targeting the central nervous system","volume":"13","author":"Pandey","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive In situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2014.02.007","article-title":"Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)\u2013block-poly(d,l)-lactic-co-glycolic acid (PEG\u2013PLGA) nanoparticles for the treatment of schizophrenia","volume":"87","author":"Piazza","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.134385_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134385_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0070","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.molpharmaceut.0c01003","article-title":"Characterization and specification of a trivalent protein-based pneumococcal vaccine formulation using an adjuvant-free nanogel nasal delivery system","volume":"18","author":"Yuki","year":"2021","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134385_bb0075","article-title":"Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles","volume":"15","author":"Baltzley","year":"2014","journal-title":"Ageing Int."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0080","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.1c00967","article-title":"Microgels and Nanogels for the delivery of poorly water-soluble drugs","author":"Dave","year":"2022","journal-title":"Mol. Pharm."},{"issue":"131491","key":"10.1016\/j.ijbiomac.2024.134385_bb0085","article-title":"Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models","volume":"267","author":"Gadhave","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127217","article-title":"Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine","volume":"253","author":"Hard","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0095","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jconrel.2020.12.050","article-title":"In situ-gelling starch nanoparticle (SNP)\/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide","volume":"330","author":"Majcher","year":"2020","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0100","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/acsbiomaterials.2c00015","article-title":"Development of an intranasal gel for the delivery of a broadly acting subunit influenza vaccine","volume":"8","author":"Varma","year":"2022","journal-title":"ACS Biomater Sci. Eng."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134385_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","article-title":"Determination of baseline human nasal pH and the effect of intranasally administered buffers","volume":"198","author":"Washington","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2015.11.028","article-title":"PLGA\/DPPC\/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment","volume":"59","author":"Karavasili","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.134385_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150043","article-title":"Preparation and characterization of octenyl succinic anhydride modified taro starch nanoparticles","volume":"11","author":"Jiang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2018.01.032","article-title":"Synthesis and characterization of octenyl succinic anhydride modified starches for food applications. A review of recent literature","volume":"80","author":"Altuna","year":"2018","journal-title":"Food Hydrocoll."},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.134385_bb0130","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.3c02575","article-title":"Disulfide-cross-linked Nanogel-based Nanoassemblies for chemotherapeutic drug delivery","volume":"15","author":"Campea","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0135","series-title":"Bioconjugate Techniques","author":"Hermanson","year":"2013"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0140","series-title":"Solvents and Solvent Effects in Organic Chemistry","author":"Reichardt","year":"2010"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0145","article-title":"Characterization of olanzapine-solid dispersions","volume":"10","author":"Krishnamoorthy","year":"2011","journal-title":"Iran. J. Pharm. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134385_bb0150","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134385_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-006-9070-6","article-title":"Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/0706743718773728","article-title":"An overview of animal models related to schizophrenia","volume":"64","author":"Winship","year":"2019","journal-title":"Can. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.134385_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/0192623312474865","article-title":"STP position paper: recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies","volume":"41","author":"Bolon","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134385_bb0180","doi-asserted-by":"crossref","DOI":"10.1021\/acs.langmuir.7b03959","article-title":"Carboxymethyl chitosan and its Hydrophobically modified derivative as pH-switchable emulsifiers","volume":"34","author":"Kalliola","year":"2018","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.134385_bb0185","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biomac.6b00777","article-title":"Synthesis and characterization of Periodate-oxidized polysaccharides: Dialdehyde Xylan (DAX)","volume":"17","author":"Amer","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0190","doi-asserted-by":"crossref","unstructured":"K. Selvaraj, K. Gowthamarajan, and V. V. S. R. Karri, \u201cNose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting,\u201d Artif. Cells, Nanomedicine Biotechnol., vol. 46, no. 8, pp. 2088\u20132095, Nov. 2018, doi:https:\/\/doi.org\/10.1080\/21691401.2017.1420073.","DOI":"10.1080\/21691401.2017.1420073"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.134385_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134385_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/S0928-0987(03)00037-X","article-title":"Limitations of the rheological mucoadhesion method: the effect of the choice of conditions and the rheological synergism parameter","volume":"18","author":"H\u00e4gerstr\u00f6m","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2011.12.020","article-title":"Comparison of in vitro methods of measuring mucoadhesion: Ellipsometry, tensile strength and rheological measurements","volume":"92","author":"Ivarsson","year":"2012","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0210","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.163.4.9909121","article-title":"The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia","volume":"163","author":"Ho","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0215","series-title":"ANSI\/AAMI\/ISO 10993-5:2009\/(R)2014; Biological Evaluation of Medical Devices \u2014Part 5: Tests for In Vitro Cytotoxicity","article-title":"Biological evaluation of medical devices \u2014Part 5: Tests for in vitro cytotoxicity","year":"2009"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0220","article-title":"Aldehydes with high and low toxicities inactivate cells by damaging distinct cellular targets","volume":"786","author":"Xie","year":"2016","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.134385_bb0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10611860108997935","article-title":"Transport of nanoparticles across the rat nasal mucosa","volume":"9","author":"Brooking","year":"2001","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121565","article-title":"Intranasal delivery of insulin by self-emulsified nanoemulsion system: in vitro and in vivo studies","volume":"616","author":"Shah","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.134385_bb0235","doi-asserted-by":"crossref","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.134385_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300536","article-title":"Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter","volume":"29","author":"Briegleb","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ijbiomac.2024.134385_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lmot.2017.03.009","article-title":"Behavioral and neural subsystems of rodent exploration","volume":"61","author":"Thompson","year":"2018","journal-title":"Learn. Motiv."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.134385_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.134385_bb0255","doi-asserted-by":"crossref","DOI":"10.1007\/s40005-020-00482-z","article-title":"Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays","volume":"50","author":"Gao","year":"2020","journal-title":"J. Pharm. Investig."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024051900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024051900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:05:43Z","timestamp":1782767143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024051900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"alternative-id":["S0141813024051900"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134385","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134385"}}